Title: Clinical contrasitive research on omeprazole and ranitidine on the treatment of Hp positive peptic ulcer
Abstract: Objective To investigate the clinical efficacy of omeprazole and ranitidine on the treatment of Hp positive peptic ulcer and discuss the clinical values and significance of omeprazole on the treatment of Hp positive peptic ulcer.Methods 82 cases of Hp positive peptic ulcer were randomly divided into the omeprazole group and the ranitidine group(each with 41 cases).Both groups were treated with omeprazole and ranitidine respecitvely.Observations were carried out about the clinical efficacy and adverse reactions of both groups.Results The recovery rate of the omeprazole group was 97.56%,while the recovery rate of the ranitidine group was 65.85%,the former was significantly higher than the latter(P 0.01).The eradication rate of the ranitidine group was 51.22%,and the eradication rate of the omeprazole group was significantly higher than that of the ranitidine(P 0.01).There was no significant difference between both groups in the incurrence rate of adverse reactions(P 0.05).Conclusion With good efficacy,complete eradication of Hp,and few adverse reactions,the triple therapy dominiated with omeprazole serves as a priority in the treatment of Hp positive peptic ulcer nowadays.
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot